Literature DB >> 11371447

Structural determinants for activation or inhibition of ryanodine receptors by basic residues in the dihydropyridine receptor II-III loop.

M G Casarotto1, D Green, S M Pace, S M Curtis, A F Dulhunty.   

Abstract

The structures of peptide A, and six other 7-20 amino acid peptides corresponding to sequences in the A region (Thr671- Leu690) of the skeletal muscle dihydropyridine receptor II-III loop have been examined, and are correlated with the ability of the peptides to activate or inhibit skeletal ryanodine receptor calcium release channels. The peptides adopted either random coil or nascent helix-like structures, which depended upon the polarity of the terminal residues as well as the presence and ionisation state of two glutamate residues. Enhanced activation of Ca2+ release from sarcoplasmic reticulum, and activation of current flow through single ryanodine receptor channels (at -40 mV), was seen with peptides containing the basic residues 681Arg Lys Arg Arg Lys685, and was strongest when the residues were a part of an alpha-helix. Inhibition of channels (at +40 mV) was also seen with peptides containing the five positively charged residues, but was not enhanced in helical peptides. These results confirm the hypothesis that activation of ryanodine receptor channels by the II-III loop peptides requires both the basic residues and their participation in helical structure, and show for the first time that inhibition requires the basic residues, but is not structure-dependent. These findings imply that activation and inhibition result from peptide binding to separate sites on the ryanodine receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11371447      PMCID: PMC1301458          DOI: 10.1016/S0006-3495(01)76240-6

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  16 in total

1.  Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling.

Authors:  T Tanabe; K G Beam; B A Adams; T Niidome; S Numa
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

2.  A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules.

Authors:  A Kumar; R R Ernst; K Wüthrich
Journal:  Biochem Biophys Res Commun       Date:  1980-07-16       Impact factor: 3.575

3.  Activation and inhibition of skeletal RyR channels by a part of the skeletal DHPR II-III loop: effects of DHPR Ser687 and FKBP12.

Authors:  A F Dulhunty; D R Laver; E M Gallant; M G Casarotto; S M Pace; S Curtis
Journal:  Biophys J       Date:  1999-07       Impact factor: 4.033

4.  Localization in the II-III loop of the dihydropyridine receptor of a sequence critical for excitation-contraction coupling.

Authors:  J Nakai; T Tanabe; T Konno; B Adams; K G Beam
Journal:  J Biol Chem       Date:  1998-09-25       Impact factor: 5.157

5.  Excitation-contraction coupling is not affected by scrambled sequence in residues 681-690 of the dihydropyridine receptor II-III loop.

Authors:  C Proenza; C M Wilkens; K G Beam
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

6.  A structural requirement for activation of skeletal ryanodine receptors by peptides of the dihydropyridine receptor II-III loop.

Authors:  M G Casarotto; F Gibson; S M Pace; S M Curtis; M Mulcair; A F Dulhunty
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

7.  Evidence for negative charge in the conduction pathway of the cardiac ryanodine receptor channel provided by the interaction of K+ channel N-type inactivation peptides.

Authors:  F C Mead; D Sullivan; A J Williams
Journal:  J Membr Biol       Date:  1998-06-01       Impact factor: 1.843

8.  Activation of the skeletal muscle calcium release channel by a cytoplasmic loop of the dihydropyridine receptor.

Authors:  X Lu; L Xu; G Meissner
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

9.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions.

Authors:  M Piotto; V Saudek; V Sklenár
Journal:  J Biomol NMR       Date:  1992-11       Impact factor: 2.835

10.  Relationship between nuclear magnetic resonance chemical shift and protein secondary structure.

Authors:  D S Wishart; B D Sykes; F M Richards
Journal:  J Mol Biol       Date:  1991-11-20       Impact factor: 5.469

View more
  11 in total

1.  The three-dimensional structural surface of two beta-sheet scorpion toxins mimics that of an alpha-helical dihydropyridine receptor segment.

Authors:  Daniel Green; Suzi Pace; Suzanne M Curtis; Magdalena Sakowska; Graham D Lamb; Angela F Dulhunty; Marco G Casarotto
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

2.  Peptide fragments of the dihydropyridine receptor can modulate cardiac ryanodine receptor channel activity and sarcoplasmic reticulum Ca2+ release.

Authors:  Angela F Dulhunty; Suzanne M Curtis; Louise Cengia; Magdalena Sakowska; Marco G Casarotto
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

3.  The elusive role of the SPRY2 domain in RyR1.

Authors:  HanShen Tae; Lan Wei; Hermia Willemse; Shamaruh Mirza; Esther M Gallant; Philip G Board; Robert T Dirksen; Marco Giovani Casarotto; Angela Dulhunty
Journal:  Channels (Austin)       Date:  2011-03-01       Impact factor: 2.581

4.  Functional implications of modifying RyR-activating peptides for membrane permeability.

Authors:  Angela F Dulhunty; Louise Cengia; Jacqui Young; Suzy M Pace; Peta J Harvey; Graham D Lamb; Yiu-Ngok Chan; Norbert Wimmer; Istvan Toth; Marco G Casarotto
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

5.  Transient loss of voltage control of Ca2+ release in the presence of maurocalcine in skeletal muscle.

Authors:  Sandrine Pouvreau; Laszlo Csernoch; Bruno Allard; Jean Marc Sabatier; Michel De Waard; Michel Ronjat; Vincent Jacquemond
Journal:  Biophys J       Date:  2006-06-16       Impact factor: 4.033

6.  A variably spliced region in the type 1 ryanodine receptor may participate in an inter-domain interaction.

Authors:  Takashi Kimura; Suzy M Pace; Lan Wei; Nicole A Beard; Robert T Dirksen; Angela F Dulhunty
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

7.  The recombinant dihydropyridine receptor II-III loop and partly structured 'C' region peptides modify cardiac ryanodine receptor activity.

Authors:  Angela F Dulhunty; Yamuna Karunasekara; Suzanne M Curtis; Peta J Harvey; Philip G Board; Marco G Casarotto
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857

8.  Cyclization of the intrinsically disordered α1S dihydropyridine receptor II-III loop enhances secondary structure and in vitro function.

Authors:  Han-Shen Tae; Yanfang Cui; Yamuna Karunasekara; Philip G Board; Angela F Dulhunty; Marco G Casarotto
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

9.  Alternative splicing of RyR1 alters the efficacy of skeletal EC coupling.

Authors:  Takashi Kimura; John D Lueck; Peta J Harvey; Suzy M Pace; Noriaki Ikemoto; Marco G Casarotto; Robert T Dirksen; Angela F Dulhunty
Journal:  Cell Calcium       Date:  2009-01-07       Impact factor: 6.817

10.  Ryanoids and imperatoxin affect the modulation of cardiac ryanodine receptors by dihydropyridine receptor Peptide A.

Authors:  Maura Porta; Paula L Diaz-Sylvester; Alma Nani; Josefina Ramos-Franco; Julio A Copello
Journal:  Biochim Biophys Acta       Date:  2008-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.